Q1 protection sales increase by £8.7 million

clock • 1 min read

Protection product sales in Q1 2017 rose by 6.6% (£8.7 million) to £140.2 million, returning to the peak levels of 2016, according to analysis from Equifax Touchstone shared exclusively with COVER.

The data, which is collated from 22 protection providers, with input from more than 11,000 advisers, revealed that decreasing term with critical illness policies grew most during the quarter, up by 15.9% on Q4 2016 to £13.5 million. This was closely followed by term policies which witnessed a 14.4% (£7.5 million) increase. Meanwhile critical illness, whole of life and relevant life policies all performed favourably, with sales increasing by 4.3% (£0.2 million), 2.6% (£0.2 million) and 1.8% (£0.05 million) respectively. Three policy types saw drops in sales, with income protection s...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

The COVER Review: Men's health, AI for insurers and weight management

The COVER Review: Men's health, AI for insurers and weight management

Week commencing 17 November 2025

COVER
clock 21 November 2025 • 1 min read
Adults aged 45-54 most at risk of financial strain: The Exeter

Adults aged 45-54 most at risk of financial strain: The Exeter

21% had no savings to fall back on

Jaskeet Briah
clock 21 November 2025 • 2 min read
AI expected to reduce workforce for large private sector firms

AI expected to reduce workforce for large private sector firms

CIPD research findings

Patrick Brusnahan
clock 10 November 2025 • 2 min read